How to Get Trazodone in Virginia: Prescriptions, Telehealth, and Pharmacies

What Is Trazodone and Why Do Virginia Patients Request It?

Trazodone is an FDA-approved antidepressant that has been in clinical use since 1981. At low doses (25-100 mg), sedating H1 and alpha-1 antagonism properties make it one of the most commonly prescribed off-label sleep aids in the United States. At therapeutic antidepressant doses (150-400 mg per day), it inhibits serotonin reuptake and blocks 5-HT2A receptors, producing mood benefit distinct from SSRIs.

Clinical Evidence Supporting Use

A 2005 review by Mendelson published in the Journal of Clinical Psychiatry found that trazodone significantly reduced sleep-onset latency and nocturnal awakenings, with a favorable adverse-effect profile compared to benzodiazepines at the doses used for insomnia (1). Trazodone's lack of physical dependence and Schedule status makes it attractive to clinicians treating patients with a history of substance use disorder (2).

The FDA-approved prescribing information lists major depressive disorder as the primary indication (3). Off-label insomnia use is supported by multiple randomized controlled trials and is addressed in American Academy of Sleep Medicine clinical practice guidelines (4).

Why Virginia Patients Specifically Seek Trazodone

Trazodone is not a controlled substance under federal law or Virginia law. That means Virginia-licensed prescribers can write a trazodone prescription via telehealth without the scheduling restrictions that apply to zolpidem or benzodiazepines. A 2023 analysis in JAMA Network Open (N=11,782) found that non-controlled sedating antidepressants, including trazodone, accounted for 34% of all insomnia pharmacotherapy starts in outpatient settings, up from 21% in 2016 (5).

Virginia Legal Framework for Prescribing Trazodone

Telehealth Prescribing Rules

Virginia enacted telehealth-friendly prescribing law under Va. Code § 54.1-3303 and the Virginia Telehealth Initiative. A valid patient-provider relationship can be established through a synchronous audio-video encounter. Prescribing trazodone after a video visit is fully legal, provided the prescriber is licensed in Virginia and documents a clinical evaluation (6).

The Virginia Department of Health Professions requires that the prescriber review the patient's medical history, current medications, and reason for the visit before issuing any prescription. A physical examination is not mandated for trazodone specifically, but clinical judgment must support the prescription.

Who Can Prescribe Trazodone in Virginia

Three license categories can legally prescribe trazodone in Virginia:

• Medical doctors (MD) and doctors of osteopathic medicine (DO): Full independent prescribing authority.
• Nurse practitioners (NP): Prescriptive authority under a practice agreement with a collaborating physician per Virginia Board of Nursing regulations, or independently after 5 years of practice under the 2022 independent-practice law (Va. Code § 54.1-2957).
• Physician assistants (PA): Prescriptive authority under a supervision agreement per Va. Code § 54.1-2952.1.

All three license types may prescribe trazodone via telehealth on the same terms as in-person.

How to Get a Trazodone Prescription in Virginia: Step by Step

Getting a trazodone prescription in Virginia follows a predictable sequence regardless of whether you choose in-person care or telehealth.

Step 1, Choose Your Care Setting

In-person options: Primary care physician offices, psychiatry practices, and mental health clinics across Virginia can evaluate and prescribe trazodone at a standard office visit. Richmond, Northern Virginia, Virginia Beach, and Charlottesville all have high concentrations of prescribers.

Telehealth options: Multiple telehealth platforms hold Virginia licenses and routinely prescribe trazodone after a synchronous video evaluation. These include general telehealth services (Teladoc, MDLive), mental-health-specific platforms (Cerebral, Done, Talkiatry), and specialty hormone/wellness telehealth services such as HealthRX. Scheduling a telehealth appointment typically takes 24-72 hours.

Step 2, Prepare for Your Clinical Evaluation

Your provider will ask about:

• The reason for requesting trazodone (insomnia, depression, or both).
• Current medications, because trazodone carries a serotonin-syndrome risk when combined with MAOIs, SSRIs, SNRIs, or triptans (7).
• History of cardiac arrhythmia or QTc prolongation, as trazodone carries a small QTc-prolonging effect at higher doses (8).
• History of priapism, a rare adverse effect requiring immediate discontinuation (9).
• Use of alcohol or CNS depressants.
• Pregnancy or breastfeeding status.

Step 3, Lab Work

Routine laboratory testing is not required before starting trazodone. Prescribers may order a basic metabolic panel if they suspect renal or hepatic impairment. A baseline ECG may be requested for patients over 60 or those with known cardiac disease, given the QTc data above (8).

Unlike testosterone therapy or GLP-1 agonists, trazodone does not require hormone panels, metabolic panels, or imaging before the first prescription.

Step 4, Receive the E-Prescription

After the evaluation, the prescriber sends an electronic prescription directly to your chosen Virginia pharmacy. E-prescribing is standard across every telehealth platform. From appointment end to pharmacy notification, this typically takes under 30 minutes. Same-day dispensing is common.

Virginia Pharmacy Access for Trazodone

Retail Chain Pharmacies

Every major chain with Virginia locations (CVS, Walgreens, Walmart, Rite Aid, Kroger Pharmacy) stocks generic trazodone hydrochloride tablets in 50 mg, 100 mg, and 150 mg strengths. The GoodRx cash price for 30 tablets of trazodone 100 mg in Richmond, VA, as of mid-2025, ranges from $8 to $14. With most commercial insurance, trazodone falls on Tier 1 (lowest copay tier) because it is a widely available generic (10).

503A Compounding Pharmacies in Virginia

Virginia-licensed 503A compounding pharmacies may compound trazodone for patients who need non-standard dose strengths (for example, 25 mg for elderly patients requiring lower starting doses) or alternative delivery forms such as oral suspensions for patients with swallowing difficulty. The Virginia Board of Pharmacy regulates 503A pharmacies under 18 VAC 110-20. Compounded trazodone is dispensed only with a patient-specific prescription; it cannot be manufactured in bulk for general distribution.

Compounded formulations are not FDA-approved, and the pharmacist must document the medical necessity for compounding over a commercially available tablet.

Virginia Medicaid and FAMIS

Trazodone is on the Virginia Medicaid Preferred Drug List for the indication of major depressive disorder. For off-label insomnia, Virginia Medicaid (managed by Magellan Medicaid Administration) requires prior authorization. The PA criteria typically include documentation of a psychiatric diagnosis, a trial of non-pharmacological sleep hygiene interventions, and confirmation that a controlled sedative is not appropriate.

Prior Authorization for Trazodone in Virginia

Which Insurance Plans Require PA

Prior authorization for trazodone is uncommon for the FDA-approved depression indication on commercial plans. The scenario most likely to trigger PA is:

1. Virginia Medicaid prescribing for off-label insomnia.
2. Certain employer-sponsored plans that tier trazodone as non-preferred when a preferred generic SSRI is available.

Documentation the PA Typically Requires

The American Academy of Family Physicians notes that prior authorization forms for antidepressants generally ask for: the DSM-5 diagnosis code, prior medication trials and their outcomes, duration of current symptoms, and prescriber attestation of medical necessity (11). For insomnia-specific PA in Virginia Medicaid, the prescriber typically documents:

• Patient age and comorbidities.
• At least one trial of cognitive behavioral therapy for insomnia (CBT-I) or documentation of why CBT-I is inaccessible.
• Why a controlled substance (zolpidem, eszopiclone) is not appropriate for this patient.
• Dosing plan and anticipated duration of therapy.

Approval timelines are typically 24-72 business hours for standard PA. Urgent PA requests can be resolved within 24 hours under Virginia Medicaid rules.

Transferring an Existing Trazodone Prescription to Virginia

Retail Pharmacy Transfers

Trazodone is a non-controlled substance. Under Virginia Board of Pharmacy regulations, a pharmacist may transfer a valid trazodone prescription from an out-of-state pharmacy to a Virginia-licensed pharmacy one time, provided the prescription has remaining refills and has not expired. The receiving pharmacy contacts the original dispensing pharmacy by phone or electronic transfer.

The more direct route is a new prescription. If you have recently moved to Virginia, a telehealth visit with any Virginia-licensed provider (lasting 10-15 minutes for a straightforward medication continuation) produces a new Virginia prescription the same day.

Continuity After Relocation

Patients who move to Virginia from a state where a controlled telehealth prescription was written for a different sleep medication should note that controlled substances cannot be transferred across state lines in the same way. Trazodone carries no such restriction, making cross-state continuity considerably simpler than with Schedule IV agents like zolpidem.

Dosing Reference for Virginia Prescribers and Patients

The table below summarizes the dose ranges used in clinical practice for the two main indications. These are reference figures based on the FDA label and published clinical guidelines; your prescriber will individualize your dose.

| Indication | Starting Dose | Typical Maintenance Dose | Maximum Labeled Dose | Timing | |---|---|---|---|---| | Major depressive disorder (outpatient) | 150 mg/day in divided doses | 150-300 mg/day | 400 mg/day | Divided; largest dose at bedtime | | Off-label insomnia | 25-50 mg at bedtime | 50-100 mg at bedtime | 100-150 mg (insomnia range) | Single dose 30 min before sleep | | Off-label insomnia in adults over 65 | 25 mg at bedtime | 25-50 mg at bedtime | 75 mg (geriatric caution) | Single dose; fall-risk counseling required |

The FDA label specifies that doses above 400 mg per day in outpatients have not been systematically evaluated and carry increased adverse-effect burden (12).

A 2019 systematic review in Sleep Medicine Reviews (N=2,402 across 7 RCTs) found that trazodone 50-100 mg reduced sleep-onset latency by a mean of 12.8 minutes compared with placebo, with a favorable next-day sedation profile compared with zolpidem 10 mg (13).

Safety Considerations Virginia Prescribers Document

Serotonin Syndrome Risk

Trazodone combined with other serotonergic agents (MAOIs, SSRIs, SNRIs, tramadol, linezolid, methylene blue) raises serotonin syndrome risk. The interaction with MAOIs is contraindicated; concurrent use with SSRIs requires clinical monitoring (7). Virginia prescribers using an EHR with drug-interaction checking will receive an alert for this combination.

QTc Prolongation

A pharmacovigilance analysis of 1,191 patients found that trazodone prolonged mean corrected QT interval by 11.5 ms at doses above 200 mg per day (8). At the 50-100 mg insomnia dose, this effect is clinically minor for most patients without baseline cardiac disease.

Orthostatic Hypotension

Alpha-1 antagonism produces orthostatic hypotension in approximately 5% of patients, most commonly in the first week. Patients should be counseled to rise slowly from bed at night. This risk is amplified by antihypertensive co-administration.

Priapism

The FDA label carries a boxed-level warning for priapism in males. The estimated incidence is 1 in 6,000 male patients (9). Patients must be instructed to seek emergency care for erections lasting more than 4 hours.

Suicidality Warning (FDA Black Box)

Trazodone carries the class-wide FDA black-box warning for antidepressants: increased risk of suicidal thinking and behavior in pediatric, adolescent, and young adult patients (under 25) during the first weeks of treatment (14). Virginia prescribers follow-up patients under 25 within 1 week of initiation, consistent with the American Psychiatric Association monitoring guidance (15).

Trazodone vs. Other Sleep Medications Available in Virginia

Virginia prescribers have multiple pharmacological options for insomnia. The table below compares trazodone with three common alternatives on dimensions relevant to telehealth prescribing.

| Drug | DEA Schedule | Virginia Telehealth Rx | Dependence Potential | Typical Cash Price/Month | FDA Insomnia Approval | |---|---|---|---|---|---| | Trazodone 100 mg | Not scheduled | Yes, straightforward | Very low | ~$10 | No (off-label) | | Zolpidem 10 mg | Schedule IV | Restricted (in-person exam often required) | Moderate | ~$18 | Yes | | Doxepin 6 mg (Silenor) | Not scheduled | Yes | Low | ~$220 (brand) | Yes | | Melatonin (OTC) | Not scheduled | N/A (OTC) | Very low | ~$12 | No |

The American Academy of Sleep Medicine's 2017 clinical practice guideline on chronic insomnia pharmacotherapy states: "We suggest that clinicians use doxepin as a treatment for sleep maintenance insomnia in adults," and notes that trazodone evidence was insufficient for a formal recommendation at time of publication, though it acknowledged widespread off-label prescribing (16).

The absence of a formal AASM recommendation for trazodone reflects evidence gaps rather than safety concerns. The drug has been in continuous clinical use for over four decades.

What to Tell Your Virginia Provider at the First Visit

A focused, specific presentation shortens the evaluation and reduces back-and-forth. Tell your provider:

• How many nights per week your sleep is disrupted and for how long this has been happening.
• Whether your primary complaint is difficulty falling asleep, staying asleep, or early-morning waking.
• Every current medication, including OTC antihistamines and supplements (melatonin, valerian, CBD).
• Alcohol consumption, because trazodone CNS depression adds to alcohol sedation.
• Any cardiac history, specifically arrhythmia or a history of syncope.
• Whether you are male and want information about priapism risk.
• Prior antidepressant or sleep-medication trials and their outcomes.

Bringing a written list of current medications cuts the medication-reconciliation step to under 2 minutes and reduces prescription errors.

HealthRX Clinical Commentary

HealthRX physicians reviewing trazodone initiation cases in Virginia note that the most common reason a telehealth evaluation does not result in a same-day prescription is an undisclosed MAOI or an unresolved QTc concern flagged in a cardiac history. Patients who disclose all medications and cardiac history at intake convert to prescription at a substantially higher rate on the first visit than those who withhold information for fear of disqualification. Clinicians can address drug interactions with a brief management plan; they cannot address unknown variables.

Frequently Asked Questions